New Study Points to SFDI as Promising Technology for Assessing Patients at Risk of Peripheral Artery Disease (PAD) - Business Wire

New Study Points to SFDI as Promising Technology for Assessing Patients at Risk of Peripheral Artery Disease (PAD)  Business Wire

A new study describes Modulim's SFDI technology as a promising imaging method for assessing compromised circulation among patients at risk for PAD.



Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management